These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 10420325)

  • 21. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The practical aspects of combination therapy with angiotensin receptor blockers and angiotensin-converting enzyme inhibitors.
    Sica DA
    J Renin Angiotensin Aldosterone Syst; 2002 Jun; 3(2):66-71. PubMed ID: 12228845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of the renin-angiotensin system, with particular reference to dual blockade treatment.
    Andersen NH; Mogensen CE
    J Renin Angiotensin Aldosterone Syst; 2001 Sep; 2(3):146-52. PubMed ID: 11881115
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical pharmacology of angiotensin II receptor antagonists].
    Hitzenberger G
    Wien Med Wochenschr; 2001; 151(7-8):151-2. PubMed ID: 11450161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Angiotensin II antagonists versus ACE inhibitors in the treatment of raised blood pressure].
    Andersen RS; Christensen S
    Ugeskr Laeger; 2001 Dec; 163(50):7036-9. PubMed ID: 11794033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angioedema associated with angiotensin II receptor antagonists: challenging our knowledge of angioedema and its etiology.
    Chiu AG; Krowiak EJ; Deeb ZE
    Laryngoscope; 2001 Oct; 111(10):1729-31. PubMed ID: 11801934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Kjeldsen SE; Julius S
    Am Heart J; 2004 Nov; 148(5):747-54. PubMed ID: 15523303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ACE inhibitors, angiotensin receptor antagonists and bradykinin.
    Schachter M
    J Renin Angiotensin Aldosterone Syst; 2000 Mar; 1(1):27-9. PubMed ID: 11967793
    [No Abstract]   [Full Text] [Related]  

  • 29. Valsartan: new preparation. Just a second-line antihypertensive drug.
    Prescrire Int; 1998 Oct; 7(37):144-5. PubMed ID: 10915419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The antihypertensive effect of peptides: a novel alternative to drugs?
    Hong F; Ming L; Yi S; Zhanxia L; Yongquan W; Chi L
    Peptides; 2008 Jun; 29(6):1062-71. PubMed ID: 18384915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Angiotensin II type-1-receptor antagonists from the viewpoint of nephrology].
    Hauser AC; Hörl WH
    Wien Med Wochenschr; 2001; 151(7-8):160-4. PubMed ID: 11450164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The renin-angiotensin system and cardiovascular disease.
    Hollenberg NK
    Blood Press Suppl; 2000; 1():5-8. PubMed ID: 11059628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [ACE inhibitor or AT1 antagonist. Is there a differential therapy?].
    Unger T; Rangoonwala B; Rosenthal J
    MMW Fortschr Med; 2002 Jun; 144(24):36-8. PubMed ID: 12134723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination therapy with ACE inhibitors/angiotensin II receptor antagonists and diuretics in hypertension.
    Waeber B
    Expert Rev Cardiovasc Ther; 2003 May; 1(1):43-50. PubMed ID: 15030296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardioprotective effect of angiotensin II receptor antagonists.
    White M
    Can J Cardiol; 1999 Nov; 15 Suppl F():10F-4F. PubMed ID: 10579747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Interview with Prof. Peter Dominiak, Lübeck. "Risk of diabetes with antihypertensive drugs is clinically relevant" (interview by Dr. Angelika Bischoff)].
    Dominiak P
    MMW Fortschr Med; 2004 Dec; 146(51-52):51. PubMed ID: 15675248
    [No Abstract]   [Full Text] [Related]  

  • 37. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers used for the treatment of hypertension appear to be safe in the early posttransplant period.
    Formica RN; Friedman AL; Lorber MI; Bia MJ
    Transplant Proc; 2004 Nov; 36(9):2675-8. PubMed ID: 15621121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antihypertensive combination therapy with ACE inhibitors].
    Scholze J; Pahl I; Rautenberg B; Thiel U
    Z Arztl Fortbild (Jena); 1992 Apr; 86(7-8):389-95. PubMed ID: 1615721
    [No Abstract]   [Full Text] [Related]  

  • 39. [In arterial hypertension: ACE inhibitors and combination therapy].
    Schrader J; Lüders S
    Pharm Unserer Zeit; 2003; 32(1):46-52. PubMed ID: 12577760
    [No Abstract]   [Full Text] [Related]  

  • 40. [Therapeutic perspectives: association of ACE inhibitors and angiotensin receptor blockers].
    Costantino S; Millozzi F; Scarlata S
    Clin Ter; 2001; 152(2):77-8. PubMed ID: 11441526
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.